Serum Institute’s export delay raises vaccine supply retaliation risk

Coronavirus 492 European Union 741 Health Care 324 India 452 U.S. 5046

Serum Institute (SI) has delayed exports of COVID-19 vaccines to the end of 2021 instead of the end of June, likely due to the accelerating pandemic in India. That will have significant implications for the rollout of vaccines in emerging markets. Exports linked to Serum Institute had already fallen to just $4.5 million in March 2021 – the lowest in two years – with Africa receiving 62.2% of exports in Q1’21. Serum Institute may face risks to its supply chain if other countries choose to prioritize the availability of components and ingredients for their own vaccine supply chains. SI’s i...

Copyright © 2021 Panjiva Supply Chain Intelligence, a product offering from S&P Global Market Intelligence Inc. All rights reserved.